Do Not Crush Dulcolax Enteric-Coated Tablets
You should never crush enteric-coated Dulcolax (bisacodyl) tablets, as the enteric coating is essential for proper drug delivery and preventing premature activation in the stomach.
Why the Enteric Coating Matters
Bisacodyl requires conversion to its active metabolite (BHPM) in the large bowel to achieve its laxative effect 1. The enteric coating serves critical functions:
- Protects the drug from gastric acid, ensuring it reaches the colon intact
- Prevents premature activation in the stomach or small intestine, which would cause gastric irritation and nausea
- Ensures targeted delivery to the large bowel where bisacodyl acts locally to enhance motility and increase water content 1
Clinical Implications of Crushing
Crushing the enteric-coated tablet would:
- Expose bisacodyl to stomach acid prematurely
- Cause significant gastric irritation and cramping
- Reduce therapeutic efficacy by preventing adequate colonic delivery
- Potentially cause adverse effects before the drug reaches its site of action
Important Caveat About Pharmaceutical Modifications
Guidelines specifically highlight that any pharmaceutical formulation modification before administration (such as crushing a capsule or tablet) requires an extra check by a pharmacist 2. This underscores the safety concerns associated with altering drug formulations.
Alternative Formulations
If a patient cannot swallow the enteric-coated tablet:
- Consider Dulcolax powder formulation (polyethylene glycol 3350), which is designed to be dissolved in 4-8 ounces of beverage 3
- Consider bisacodyl suppositories for rectal administration
- Consider bisacodyl micro-enema preparations 4
These alternatives provide safe options for patients with swallowing difficulties without compromising drug delivery or causing adverse effects.